Abstract Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease
caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In response to …

Antibodies against platelet factor 4 (PF4), a protein released from alpha-granules of
activated platelets, may cause a number of pathophysiological conditions. The most …

Background Vaccine‐induced thrombotic thrombocytopenia (VITT) is a rare complication of
adenovirus‐based vaccines aimed to prevent and minimize COVID‐19 and related …

Abstract Thrombosis and Thrombocytopenia Syndrome (TTS) has been associated with the
AstraZencea (AZ) COVID-19 vaccine (Vaxzevria). Australia has reported low TTS incidence …

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe prothrombotic
complication of adenoviral vaccines, including the ChAdOx1 nCoV-19 (Vaxzevria) vaccine …

Since early 2020, the world has been embroiled in an ongoing viral pandemic with SARS‐
CoV‐2 and emerging variants resulting in mass morbidity and an estimated 6 million deaths …

There is no certainty in change, other than change is certain. As Seminars in Thrombosis
and Hemostasis celebrates 50 years of publication, I felt it appropriate to reflect on my own …

D-dimer containing species are soluble fibrin degradation products derived from plasmin-
mediated degradation of cross-linked fibrin, ie,'D-dimer'. D-dimer can hence be considered a …

Summary Platelet factor 4 (PF4), a protein stored in the alpha-granules of platelets and
released upon activation, forms cationic tetramers that bind with various polymeric anions …

Vaccine‐induced thrombotic thrombocytopenia (VITT) is a rare, but serious, syndrome
characterised by thrombocytopenia, thrombosis, a markedly raised D‐dimer and the …